MMWR Mpox Reports

December 30, 2022

• Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022
• Demographic and Clinical Characteristics of Mpox in Persons Who Previously Received 1 Dose of JYNNEOS Vaccine Compared with Mpox in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022
• Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022

December 9, 2022

• Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
• Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022

November 11, 2022

• Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response — United States, May 17–October 6, 2022

November 4, 2022

• Epidemiologic and Clinical Features of Children and Adolescents Aged <18 Years with Monkeypox — United States, May 17–September 24, 2022
• Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022

October 28, 2022

• Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
• Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival — Louisiana, August 9–September 5, 2022
• A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events — Georgia, August 27–September 5, 2022

October 21, 2022 

• Ocular Monkeypox — United States, July–September 2022
• Monkeypox Virus Infection Resulting from an Occupational Needlestick — Florida, 2022

October 7, 2022

• Monkeypox Case Investigation — Cook County Jail, Chicago, Illinois, July–August 2022
• Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022

September 23, 2022

• Monkeypox in a Young Infant – Florida, 2022
• Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Monkeypox Patients — Colorado, 2022
• Two Cases of Monkeypox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022

September 9, 2022

• HIV and Sexually Transmitted Infections Among Persons with Monkeypox — Eight U.S. Jurisdictions, May 17–July 22, 2022
• Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox — United States, 2022
• Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

August 26, 2022

• Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox Transmission — United States, August 2022
• Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex with Men — United States, 2022
• High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection — Utah, June 2022

August 12, 2022

• Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022
• Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022

July 15, 2022

• Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022

June 10, 2022

• Monkeypox Outbreak — Nine States, May 2022

June 3, 2022

• Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022